Plasma miR-200b in ovarian carcinoma patients: distinct pattern of pre/post-treatment variation compared to CA-125 and potential for prediction of progression-free survival

Nikiforos-Ioannis Kapetanakis(Université Paris-Saclay), Pierre Busson(Université Paris-Sud)
Oncotarget
September 21, 2015
Cited by 34


Related Papers